Johnson & Johnson (JNJ) had its price target raised by Morgan Stanley from $262.00 to $267.00. They now have an "overweight" rating on the stock.
Johnson & Johnson Showcases New Clinical Data for TECNIS PureSee IOL at ASCRS 2026 Demonstrating Excellent Contrast Sensitivity and Extended Range of Vision
Johnson & Johnson PFA Launch Puts VARIPULSE Pro And Valuation In Focus [Yahoo! Finance]
Johnson & Johnson (JNJ) Increases Yet Falls Behind Market: What Investors Need to Know [Yahoo! Finance]
How Raw Sugar Living's CEO Is Fighting Inflation In The Beauty Aisle [Forbes]